Skip to content

Clinical trials

Adenocarcinoma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Poland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20093
20101
20122
20131
20163
20171
20181
20202
20211
20221
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting5
Recruiting5
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.2
AstraZeneca2
Eli Lilly and Company2
Maia Biotechnology2
Medical University of Lublin2
Pfizer2
Affidea Nu-med Center of Oncological DIagnostics and Therapy1
Checkpoint Therapeutics, Inc.1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma23
Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Stomach Neoplasms6
Carcinoma4
Lung Diseases3
Lung Neoplasms3
Neoplasms by Histologic Type3
Neoplasms by Site3
Pancreatic Neoplasms3

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.